...
首页> 外文期刊>Journal of the International Aids Society >Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa
【24h】

Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa

机译:南非Khayelitsha的HIV阳性青年对HIV确诊的即时诊断CD4检测的ART启动的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

IntroductionDespite the rapid expansion of antiretroviral therapy (ART) programmes in developing countries, pre-treatment losses from care remain a challenge to improving access to treatment. Youth and adolescents have been identified as a particularly vulnerable group, at greater risk of loss from both pre-ART and ART care. Point-of-care (POC) CD4 testing has shown promising results in improving linkage to ART care. In Khayelitsha township, South Africa, POC CD4 testing was implemented at a clinic designated for youth aged 12–25 years. We assessed whether there was an associated reduction in attrition between HIV testing, assessment for eligibility and ART initiation.MethodsA before-and-after observational study was conducted using routinely collected data. These were collected on patients from May 2010 to April 2011 (Group A) when baseline CD4 count testing was performed in a laboratory and results were returned to the clinic within two weeks. Same-day POC CD4 testing was implemented in June 2011, and data were collected on patients from August 2011 to July 2012 (Group B).ResultsA total of 272 and 304 youth tested HIV-positive in Group A and Group B, respectively. Group B patients were twice as likely to have their ART eligibility assessed compared to Group A patients: 275 (90%) vs. 183 (67%) [relative risk (RR)=2.4, 95% CI: 1.8–3.4, p<0.0001]. More patients in World Health Organization (WHO) Stage 1 disease (85% vs. 69%), with CD4 counts≥350 cells/μL (58% vs. 35%) and more males (13% vs. 7%) were detected in Group B. The proportion of eligible patients who initiated ART was 50% and 44% (p=0.6) in Groups B and A, respectively; and 50% and 43% (p=0.5) when restricted to patients with baseline CD4 count≤250 cells/μL. Time between HIV-testing and ART initiation was reduced from 36 to 28 days (p=0.6).DiscussionPOC CD4 testing significantly improved assessment for ART eligibility. The improvement in the proportion initiating ART and the reduction in time to initiation was not significant due to sample size limitations.ConclusionsPOC CD4 testing reduced attrition between HIV-testing and assessment of ART eligibility. Strategies to improve uptake of ART are needed, possibly by improving patient support for HIV-positive youth immediately after diagnosis.
机译:简介尽管发展中国家迅速扩大了抗逆转录病毒疗法(ART)计划,但护理引起的治疗前损失仍然是改善获得治疗的机会的挑战。青年和青少年已被确定为特别脆弱的人群,他们在接受抗逆转录病毒治疗前和抗逆转录病毒治疗时都有更大的损失风险。即时医疗点(POC)CD4测试在改善与ART护理的联系方面显示出令人鼓舞的结果。在南非的Khayelitsha镇,针对12至25岁年轻人的诊所进行了POC CD4测试。我们评估了艾滋病毒检测,资格评估和抗病毒治疗之间的损耗是否有相关的降低。方法采用常规收集的数据进行前后观察研究。这些样本是在2010年5月至2011年4月(A组)的患者身上收集的,当时在实验室中进行了基线CD4计数测试,并将结果在两周内返回诊所。 2011年6月实施了当天POC CD4检测,收集了2011年8月至2012年7月(B组)患者的数据。结果A组和B组中分别有272名和304名青年检测出HIV阳性。与A组患者相比,B组患者接受ART资格评估的可能性是A组患者的两倍:275(90%)比183(67%)[相对风险(RR)= 2.4,95%CI:1.8-3.4,p < 0.0001]。世界卫生组织(WHO)第1期疾病患者更多(85%对69%),CD4计数≥350细胞/μL(58%对35%),男性更多(13%对7%)。在B组和A组中,开始接受抗病毒治疗的合格患者比例分别为50%和44%(p = 0.6)。当基线CD4计数≤250细胞/μL的患者使用时,分别为50%和43%(p = 0.5)。从HIV检测到开始抗病毒治疗的时间从36天减少到28天(p = 0.6)。DiscussionPOCCD4检测显着改善了抗病毒治疗资格的评估。由于样本量的限制,开始抗病毒治疗的比例的提高和开始时间的减少并不显着。结论POC CD4检测减少了HIV检测和抗病毒治疗资格评估之间的消耗。需要采取策略来提高抗逆转录病毒疗法的吸收,可能是通过在诊断后立即改善对艾滋病毒抗体阳性青年的患者支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号